Tocqueville Asset Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13
| Closed | -$57.4K | – | 549 |
|
|
2023
Q2 | $57.4K | Sell |
13
-2
| -13% | -$8.83K | ﹤0.01% | 527 |
|
|
2023
Q1 | $40.1K | Buy |
15
+1
| +7% | +$2.67K | ﹤0.01% | 524 |
|
|
2022
Q4 | $37.3K | Hold |
14
| – | – | ﹤0.01% | 571 |
|
|
2022
Q3 | $57K | Sell |
14
-17
| -55% | -$69.2K | ﹤0.01% | 589 |
|
|
2022
Q2 | $81K | Hold |
31
| – | – | ﹤0.01% | 651 |
|
|
2022
Q1 | $99K | Hold |
31
| – | – | ﹤0.01% | 695 |
|
|
2021
Q4 | $193K | Sell |
31
-1
| -3% | -$6.23K | ﹤0.01% | 717 |
|
|
2021
Q3 | $299K | Sell |
32
-9
| -22% | -$84.1K | ﹤0.01% | 625 |
|
|
2021
Q2 | $419K | Sell |
41
-11
| -21% | -$112K | 0.01% | 590 |
|
|
2021
Q1 | $992K | Buy |
52
+25
| +93% | +$477K | 0.02% | 450 |
|
|
2020
Q4 | $166K | Buy |
27
+17
| +170% | +$105K | ﹤0.01% | 688 |
|
|
2020
Q3 | $37K | Sell |
10
-37
| -79% | -$137K | ﹤0.01% | 643 |
|
|
2020
Q2 | $183K | Sell |
47
-3
| -6% | -$11.7K | ﹤0.01% | 631 |
|
|
2020
Q1 | $94K | Buy |
+50
| New | +$94K | ﹤0.01% | 621 |
|